Nine Monthly Results Results Snapshot
Figures in Cr
Consolidate Nine Monthly Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Net Sales
4,687.86
4,191.59
4,127.28
2,839.59
3,297.70
2,575.13
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
4,687.86
4,191.59
4,127.28
2,839.59
3,297.70
2,575.13
Raw Material Cost
1,645.68
1,384.91
1,447.45
1,278.38
1,443.91
1,306.67
Purchase of Finished goods
4.33
11.39
16.31
12.44
16.86
12.07
(Increase) / Decrease In Stocks
1.59
206.13
109.95
29.77
103.16
-218.42
Employee Cost
1,217.27
1,028.20
905.29
300.44
244.32
233.07
Power Cost
149.83
146.55
172.11
95.32
69.93
55.33
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
-0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
552.63
493.00
501.74
266.90
257.72
211.85
Total Expenditure (Excl Depreciation)
3,571.33
3,270.18
3,152.85
1,983.25
2,135.90
1,600.57
Operating Profit (PBDIT) excl Other Income
1,116.53
921.41
974.43
856.34
1,161.80
974.56
Other Income
204.86
169.58
128.09
201.53
158.71
87.56
Operating Profit (PBDIT)
1,321.39
1,090.99
1,102.52
1,057.87
1,320.51
1,062.12
Interest
23.25
34.55
16.24
5.24
3.21
2.39
Exceptional Items
-24.35
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
1,273.79
1,056.44
1,086.28
1,052.63
1,317.30
1,059.73
Depreciation
315.01
282.12
251.96
109.19
79.22
73.86
Profit Before Tax
958.79
774.32
834.31
943.43
1,238.07
985.87
Tax
298.14
262.34
254.27
241.07
312.30
249.31
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
660.65
511.98
580.04
702.36
925.76
736.56
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
660.65
511.98
580.04
702.36
925.76
736.56
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
660.65
511.98
580.04
702.36
925.76
736.56
Equity Capital
16.48
16.48
16.47
16.47
16.43
16.33
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
Diluted Earnings per share
15.87
12.42
11.65
14.08
16.62
12.82
Operating Profit Margin (Excl OI)
23.82%
21.98%
23.61%
30.16%
35.23%
37.85%
Gross Profit Margin
27.17%
25.2%
26.32%
37.07%
39.95%
41.15%
PAT Margin
14.09%
12.21%
14.05%
24.73%
28.07%
28.6%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Nine Monthly Analysis Highlights
Net Sales
YoY Growth in nine months ended Dec 2025 is 11.84% vs 1.56% in Dec 2024
Consolidate Net Profit
YoY Growth in nine months ended Dec 2025 is 29.04% vs -11.73% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in nine months ended Dec 2025 is 21.18% vs -5.44% in Dec 2024
Interest
YoY Growth in nine months ended Dec 2025 is -32.71% vs 112.75% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in nine months ended Dec 2025 has improved from Dec 2024
Compare Nine Monthly Results Of Gland Pharma With
Figures in Cr
Consolidate Nine Monthly Results
Change(INR)
Change(%)
Net Sales
4,687.86
4,031.22
656.64
16.29%
Other Operating Income
0.00
0.00
0.00
Total Operating income
4,687.86
4,031.22
656.64
16.29%
Raw Material Cost
1,645.68
659.75
985.93
149.44%
Purchase of Finished goods
4.33
158.44
-154.11
-97.27%
(Increase) / Decrease In Stocks
1.59
60.76
-59.17
-97.38%
Employee Cost
1,217.27
950.43
266.84
28.08%
Power Cost
149.83
0.00
149.83
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
552.63
1,140.42
-587.79
-51.54%
Total Expenditure (Excl Depreciation)
3,571.33
2,969.80
601.53
20.25%
Operating Profit (PBDIT) excl Other Income
1,116.53
1,061.42
55.11
5.19%
Other Income
204.86
110.64
94.22
85.16%
Operating Profit (PBDIT)
1,321.39
1,172.06
149.33
12.74%
Interest
23.25
13.75
9.50
69.09%
Exceptional Items
-24.35
0.00
-24.35
Gross Profit (PBDT)
1,273.79
1,158.31
115.48
9.97%
Depreciation
315.01
127.77
187.24
146.54%
Profit Before Tax
958.79
1,030.54
-71.75
-6.96%
Tax
298.14
241.24
56.90
23.59%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
660.65
789.30
-128.65
-16.30%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
660.65
789.30
-128.65
-16.30%
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
660.65
789.30
-128.65
-16.30%
Equity Capital
16.48
25.07
-8.59
-34.26%
Face Value
1.00
2.00
0.00
Reserves
0.00
0.00
0.00
Gross Profit Margin
27.17%
28.73%
0.00
-1.56%
PAT Margin
14.09%
19.58%
0.00
-5.49%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Nine Monthly - Net Sales
Net Sales 4,687.86 Cr
in Dec 2025Figures in Cr
YoY Growth in nine months ended Dec 2025 is 11.84% vs 1.56% in Dec 2024
Nine Monthly - Consolidate Net Profit
Consolidate Net Profit 660.65 Cr
in Dec 2025Figures in Cr
YoY Growth in nine months ended Dec 2025 is 29.04% vs -11.73% in Dec 2024
Nine Monthly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 1,116.53 Cr
in Dec 2025Figures in Cr
YoY Growth in nine months ended Dec 2025 is 21.18% vs -5.44% in Dec 2024
Nine Monthly - Interest
Interest 23.25 Cr
in Dec 2025Figures in Cr
YoY Growth in nine months ended Dec 2025 is -32.71% vs 112.75% in Dec 2024
Nine Monthly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 23.82%
in Dec 2025Figures in %
YoY Growth in nine months ended Dec 2025 has improved from Dec 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
